Views & Analysis Manchester setting the pace in NHS move to outcomes-based de... The NHS is moving rapidly towards integrated care models – and outcomes-based deals with pharma will also play a role.
Views & Analysis Just unveiled, the next big idea for England’s NHS Trailblazing ‘Accountable Care Systems’ announced in England to integrate health and social care.
News Jazz gets first FDA nod for HER2 bispecific Ziihera Jazz Pharma has claimed FDA approval for its HER2-directed bispecific antibody Ziihera as a treatment for biliary tract cancer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends